![John Chiminski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Chiminski
Directeur/Membre du Conseil chez
QUIDELORTHO CORPORATION
Fortune : 121 763 $ au 31/05/2026
Profil
Actuellement, John R. Chiminski occupe le poste de président-directeur général de Catalent, Inc. et de président, directeur général et administrateur de Catalent Pharma Solutions, Inc. et de président-directeur général de Juniper Pharmaceuticals, Inc. (toutes deux sont des filiales de Catalent, Inc.). M. Chiminski est également membre du conseil d'administration du HealthCare Institute of New Jersey. John R. Chiminski a précédemment occupé le poste de président-directeur général de GE Healthcare Medical Diagnostics et de vice-président et directeur général de l'activité mondiale de résonance magnétique chez GE Healthcare Ltd. Il est titulaire d'un diplôme de premier cycle de l'université d'État du Michigan, d'un diplôme d'études supérieures de l'université Purdue et d'un diplôme d'études supérieures de la Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/05/2026 | 9 352 ( 0,01% ) | 121 763 $ | 31/05/2026 |
Postes actifs de John Chiminski
| Sociétés | Poste | Début |
|---|---|---|
| QUIDELORTHO CORPORATION | Directeur/Membre du Conseil | 06/12/2024 |
Redwood Bioscience, Inc.
 Redwood Bioscience, Inc. BiotechnologyHealth Technology Develops precision protein-chemical engineering technology | Directeur Général | - |
Catalent Indiana LLC
 Catalent Indiana LLC Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Directeur Général | - |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | Directeur/Membre du Conseil | 15/06/2010 |
Anciens postes connus de John Chiminski
| Sociétés | Poste | Fin |
|---|---|---|
| BRUKER CELLULAR ANALYSIS, INC. | Directeur/Membre du Conseil | 02/10/2023 |
| CATALENT, INC. | Directeur Général | 01/07/2022 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Directeur Général | 01/07/2022 |
DJO Finance LLC
 DJO Finance LLC Medical SpecialtiesHealth Technology Develops, manufactures and distributes medical devices | Directeur/Membre du Conseil | 28/10/2015 |
DJO Global, Inc.
 DJO Global, Inc. Medical SpecialtiesHealth Technology Manufactures and sells orthopedic devices for physical therapy | Directeur/Membre du Conseil | 01/10/2015 |
Formation de John Chiminski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
DJO Global, Inc.
DJO Global, Inc. Medical SpecialtiesHealth Technology Manufactures and sells orthopedic devices for physical therapy | Health Technology |
DJO Finance LLC
DJO Finance LLC Medical SpecialtiesHealth Technology Develops, manufactures and distributes medical devices | Health Technology |
Redwood Bioscience, Inc.
Redwood Bioscience, Inc. BiotechnologyHealth Technology Develops precision protein-chemical engineering technology | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
HealthCare Institute of New Jersey
HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | |
Catalent Indiana LLC
Catalent Indiana LLC Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Graham Packaging Holdings Co. (Pennsylvania)
 Graham Packaging Holdings Co. (Pennsylvania) Chemicals: SpecialtyProcess Industries Manufactures and sells plastic containers | Process Industries |
GE Healthcare Medical Diagnostics | |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalent, Inc.
 Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Berkeley Lights, Inc.
 Berkeley Lights, Inc. Packaged SoftwareTechnology Services Develops and commercializes platforms for bio-pharmaceutical, genomic and cellular therapy applications | Technology Services |
QuidelOrtho Corp.
 QuidelOrtho Corp. Medical SpecialtiesHealth Technology Manufactures in vitro diagnostics products | Health Technology |
PhenomeX, Inc.
 PhenomeX, Inc. Medical SpecialtiesHealth Technology Develops and sells products for cell therapy, functional analysis & antibody profiling services | Health Technology |
